Amphastar Pharmaceuticals Inc [AMPH] stock prices are up 1.48% to $38.48 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AMPH shares have gain 8.61% over the last week, with a monthly amount drifted -11.68%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] stock has seen the most recent analyst activity on November 22, 2024, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $55. Previously, JP Morgan started tracking the stock with Overweight rating on March 05, 2024, and set its price target to $60. On November 17, 2023, BofA Securities initiated with a Neutral rating and assigned a price target of $63 on the stock. CapitalOne started tracking with a Overweight rating for this stock on July 29, 2022, and assigned it a price target of $44. In a note dated January 07, 2022, Piper Sandler upgraded an Overweight rating on this stock and boosted its target price from $21 to $28.
The stock price of Amphastar Pharmaceuticals Inc [AMPH] has been fluctuating between $34.69 and $56.88 over the past year. Currently, Wall Street analysts expect the stock to reach $66 within the next 12 months. Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] shares were valued at $38.48 at the most recent close of the market. An investor can expect a potential return of 71.52% based on the average AMPH price forecast.
Analyzing the AMPH fundamentals
The Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] reported sales of 723.55M for trailing twelve months, representing a surge of 5.90%. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at 0.3%, Pretax Profit Margin comes in at 0.26%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.23 and Total Capital is 0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 37.52 points at the first support level, and at 36.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 39.18, and for the 2nd resistance point, it is at 39.88.
Ratios To Look Out For
It’s worth pointing out that Amphastar Pharmaceuticals Inc [NASDAQ:AMPH]’s Current Ratio is 3.43. As well, the Quick Ratio is 2.61, while the Cash Ratio is 1.21. Considering the valuation of this stock, the price to sales ratio is 2.56, the price to book ratio is 2.56 and price to earnings (TTM) ratio is 12.80.
Transactions by insiders
Recent insider trading involved Zhou Rong, SENIOR EVP, PRODUCTION CENTER, that happened on Dec 13 ’24 when 8000.0 shares were sold. SENIOR EVP, PRODUCTION CENTER, Zhou Rong completed a deal on Dec 12 ’24 to sell 7000.0 shares. Meanwhile, Director PRINS RICHARD K sold 10000.0 shares on Dec 09 ’24.
